DocGo Q3 2023 EPS $0.05 Misses $0.06 Estimate, Sales $186.55M Beat $147.70M Estimate
Portfolio Pulse from totan@benzinga.com
DocGo (NASDAQ:DCGO) reported Q3 2023 earnings of $0.05 per share, missing the analyst consensus estimate of $0.06 by 16.67%. However, the company's quarterly sales of $186.55 million beat the analyst consensus estimate of $147.70 million by 26.31%. This represents a 66.67% increase in earnings and a 78.83% increase in sales compared to the same period last year.
November 06, 2023 | 9:23 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
DocGo's Q3 2023 earnings missed estimates but sales exceeded expectations. This mixed result could lead to uncertain short-term price movements.
DocGo's earnings miss could negatively impact the stock price, but this may be offset by the better-than-expected sales figures. The net effect on the stock price is uncertain in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100